Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | MMP8 | P22894 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL805646 | 1.00 | GAA (0.62) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL260296 | 1.00 | GAA (0.62) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrogen Sulfide SCHEMBL28874620 | 0.98 | GAA (0.60) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrogen Sulfide SCHEMBL27877648 | 0.98 | GAA (0.60) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| Hydrazine SCHEMBL27358872 | 0.96 | GAA (0.59) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL28434406 | 0.90 | GAA (0.52) | GAAKDM4EL3MBTL1TDP1MMP8 | |
| SCHEMBL5972492 | 0.89 | MMP8 (0.56) | GAAKDM4ETDP1MMP8MEN1 | |
| SCHEMBL5811954 | 0.87 | MMP8 (0.54) | GAAKDM4EMMP8MEN1KMT2A | |
| SCHEMBL10635430 | 0.87 | MMP8 (0.54) | GAAKDM4EMMP8MEN1KMT2A | |
| SCHEMBL2222145 | 0.86 | GAA (0.55) | GAAKDM4EL3MBTL1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421200-B2 | Manganese-catalysed hydrogenation of esters | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2025-09-23 | — | — | US | disclosed |
| CN-120136669-A | Manganese catalyzed ester hydrogenation | 圣安德鲁斯大学董事会 | 2025-06-13 | — | — | CN | disclosed |
| EP-3737663-B1 | MANGANESE-CATALYSED HYDROGENATION OF ESTERS | UNIV COURT UNIV ST ANDREWS (GB) | 2023-02-22 | — | — | EP | disclosed |
| EP-3737663-B1 | MANGANESE-CATALYSED HYDROGENATION OF ESTERS | UNIV COURT UNIV ST ANDREWS (GB) | 2023-02-22 | — | — | EP | disclosed |
| US-20210053932-A1 | MANGANESE-CATALYSED HYDROGENATION OF ESTERS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2021-02-25 | — | — | US | disclosed |
| CN-106318278-A | Quick drying glue spray | 无锡万能胶粘剂有限公司 | 2017-01-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12421200-B2 | Manganese-catalysed hydrogenation of esters | ADH5, HDHD5, ADH1A | GAA 1156/4885KDM4E 1404/4885L3MBTL1 2046/4885 |
| US-20210053932-A1 | MANGANESE-CATALYSED HYDROGENATION OF ESTERS | ADH5, HDHD5, ADH1A | GAA 1156/4885KDM4E 1404/4885L3MBTL1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.